# Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer

> **NCT00195039** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 47 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu -J591)

## Key facts

- **NCT ID:** NCT00195039
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2012-02
- **Final completion:** 2013-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195039, "Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00195039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*